Macrocycles in Drug Discovery
Jeremy Levin
2014 оны 10-р сар · Drug Discovery Series 40-р ном · Royal Society of Chemistry
Электрон ном
528
Хуудас
reportҮнэлгээ болон шүүмжийг баталгаажуулаагүй Нэмэлт мэдээлэл авах
Энэ электрон номын тухай
This book reviews macrocycles in drug discovery, both those of natural origin and semi-synthetic derivatives of natural products, and those designed and synthesized based on principles of medicinal chemistry.
The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein–protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug–protein interactions that cover a larger surface area than traditional small molecules.
A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia.
The medicinal chemistry of macrocyclic natural products is interesting in itself, but lessons learned from these compounds, in terms of the relationship between structure and desirable physicochemical properties, are now informing the design of fully synthetic macrocyclic drug candidates against a variety of targets including kinases, ATPases, proteases, GPCRs and others. Furthermore, as more non-classical drug targets, such as protein–protein interactions, are pursued in the pharmaceutical industry, macrocyclic molecules are generating increasing interest as they offer a way to provide drug–protein interactions that cover a larger surface area than traditional small molecules.
A variety of macrocycles have become important drugs or have been identified as leads to marketed drugs. This text will discuss these compounds, their pharmacology and synthesis, in the context of their broad chemotype as compounds composed of large rings. Providing a wide reaching review of this important area in a single volume, this book will be of interest to biochemists, pharmaceutical scientists and medicinal chemists working in industry or academia.
Зохиогчийн тухай
Jeremy Levin is currently a Director of Medicinal Chemistry at Boehringer Ingelheim Pharmaceuticals, with a total of 25 years of experience in the pharmaceutical industry. He has worked in multiple therapeutic areas, including CNS, inflammation and immunology, and oncology. Dr Levin has authored or co-authored more than 70 papers in peer reviewed journals and served as an inventor on more than 60 issued U.S patents.
Энэ электрон номыг үнэлэх
Санал бодлоо хэлнэ үү.
Унших мэдээлэл
Ухаалаг утас болон таблет
Андройд болон iPad/iPhone-д Google Ном Унших аппыг суулгана уу. Үүнийг таны бүртгэлд автоматаар синк хийх бөгөөд та хүссэн газраасаа онлайн эсвэл офлайнаар унших боломжтой.
Зөөврийн болон ердийн компьютер
Та компьютерийн веб хөтчөөр Google Play-с авсан аудио номыг сонсох боломжтой.
eReaders болон бусад төхөөрөмжүүд
Kobo Цахим ном уншигч гэх мэт e-ink төхөөрөмжүүд дээр уншихын тулд та файлыг татаад төхөөрөмж рүүгээ дамжуулах шаардлагатай болно. Файлуудаа дэмжигддэг Цахим ном уншигч руу шилжүүлэхийн тулд Тусламжийн төвийн дэлгэрэнгүй зааварчилгааг дагана уу.
